Arca
Skip to content
Tools
Tools

Pefakit Apc-R Factor V Leiden Controls

Plasma, Coagulation Control. 510(k) K042760, from Pentapharm , Ltd. (Washington, DC). Product code GGN, class 2.

As of Nov 18, 2026, K042760 is an FDA 510(k) held by Pentapharm , Ltd., substantially equivalent on Dec 22, 2004 after 78 days, with no recalls tied to it in FDA's recall database.

  • Review time: 78 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The device is a box containing lyophilized pooled plasmas from donors genotyped for the factor V Leiden mutation (FV: Q506) to be reconstituted with water by the user. Controls contain pooled plasmas of either donors with heterozygous FV:Q506 mutation or normal wild-type pattern.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Record

Type
Abbreviated
Received
Oct 5, 2004
Review panel
Hematology
Regulation
21 CFR 864.5425

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.